Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from the University of Miami is evaluating biomarkers of ocular surface damage related to topical ocular hypotensive medications in gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Miami | Conditions: Glaucoma, Open-Angle Glaucoma | Phase 4 | Status: RECRUITING